QNRX Competitors & Alternatives

Compare Quoin Pharmaceuticals Ltd DRC with similar stocks in the same industry

Biotechnology

QNRX

Main Stock
$3.28
-2.35%
Tradestie Score
44
Market Cap
$4.25M
P/E Ratio
7.6
Analyst Upside
+521.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: topical drug formulations for rare dermatological diseases
Major Customers 3
specialty pharmacies dermatology clinics rare disease patients
Critical Suppliers 2
contract manufacturing organizations CROs
Direct Ecosystem Rivals 0
Sole-source / monopoly positioning in sub-sector.

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
ILAG Intelligent Living Application Group Inc. Ordinary Shares
$1.53
-16.85%
$13.23M - 47 Compare
KPRX Kiora Pharmaceuticals, Inc. Common Stock
$0.72
-12.28%
$9.72M - 47 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.36
-0.17%
$7.21M - 52 Compare
REVB Revelation Biosciences, Inc. Common Stock
$3.50
-5.15%
$3.42M - 47 Compare
VRAX Virax Biolabs Group Limited Ordinary Shares
$0.33
-12.89%
$2.69M - 46 Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry